ESCRS - PO011 - DOES THE USE OF AN IMPLANTABLE COLLAMER LENS HAVE A ROLE IN A PUBLIC SECTOR HOSPITAL?

DOES THE USE OF AN IMPLANTABLE COLLAMER LENS HAVE A ROLE IN A PUBLIC SECTOR HOSPITAL?

Published 2025 - 29th ESCRS Winter Meeting

Reference: PO011 | Type: Presented Poster & Poster | DOI: 10.82333/3bad-vp59

Authors: Dionysios Triantafyllou* 1 , Grace Kiew 1 , Fuad Alhamdan AlHussein 1 , Jan Sniatecki 1 , Harinderjeet Sandhu 1 , David Anderson 1 , Parwez Hossain 1 , Aristides Konstantopoulos 1

1Ophthalmology,University Hospital Southampton,Southampton,United Kingdom

Purpose

To report outcomes of the use of Phakic intraocular lenses/implantable collamer lenses (ICL) in a public sector hospital (NHS) after corneal transplantation or cornea scarring.
 

Setting

University Hospital Southampton NHS Foundation Trust, UK.
 

Methods

All ICL procedures between September 2023 and September 2024 were reviewed for this report. Eight patients had undergone ICL implantation (mean age 35 years): six with prior Deep Anterior Lamellar Keratoplasty (DALK) or Penetrating Keratoplasty (PK), one with previous Keraring insertion and one with significant astigmatism from post-infectious corneal scarring. All patients had a toric myopic Visian ICL implanted.  

Results

Post-operative uncorrected distance visual acuity (UDVA) improved from 1.04logMAR to 0.61logMAR, with best corrected visual acuity (BCVA) improving from 0.47logMAR to 0.14logMAR post-operatively. Post-operative refraction was available for six patients, with mean achieved post-operative spherical equivalent being -1.04D±0.25. The deviation from the predicted refractive outcome was -2.38D±1.39 (from -6.94D±2.15 pre-operatively). One patient required ICL realignment with subsequent good visual acuity. One patient with a high pressure and high vault lost over 2 lines of Snellen visual acuity post-operatively but was lost to follow up early on. One patient is planned for further arcuate keratotomies to correct residual astigmatism (initial 10D astigmatism). Overall, six patients (75%) were satisfied with the post-operative outcome after ICL implantation. 
 

Conclusion

 Our experience with the use of toric ICL implants within the NHS supports their use in a public sector healthcare. Patient satisfaction is high, with improvements in both post-operative BCVA and UDVA. Refractive outcomes may be less predictable compared to typical refractive ICL cases but their use can optimise the outcomes of highly ammetropic grafts, reduce the use of hard contact lenses and associated disadvantages, and improve the quality of vision and life for patients.